Oxidative stress is involved in fatigue induced by overnight deskwork as assessed by increase in plasma tocopherylhydroqinone and hydroxycholesterol

Biological Psychology

Volumn 94, Issue 3, 2013, Pages 527-533

  Shichiri, Mototada ^a   Harada, Nobuyoshi ^a,b   Ishida, Noriko ^a   Komaba, Lilian Kaede ^a   Iwaki, Sunao ^a   Hagihara, Yoshihisa ^a   Niki, Etsuo ^a   Yoshida, Yasukazu ^a  

^a NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY AIST   (Japan)

^b Flicker Health Management Corp   (Japan)

Author keywords

Tocopherylquinone; Critical flicker frequency; Fatigue; Lipid peroxidation; Overnight deskwork

Indexed keywords

7BETA HYDROXYCHOLESTEROL; ALPHA TOCOPHEROL; ALPHA TOCOPHERYLQUINONE; CHOLESTEROL; QUINONE DERIVATIVE; UBIDECARENONE; UBIQUINOL 10; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CHOLESTEROL BLOOD LEVEL; CRITICAL FLICKER FUSION; FATIGUE; HUMAN; HUMAN EXPERIMENT; LIPID PEROXIDATION; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NORMAL HUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; QUESTIONNAIRE OF SUBJECTIVE SYMPTOMS OF FATIGUE; SELF EVALUATION; SLEEP DEPRIVATION; VISUAL ANALOG SCALE; WORK SCHEDULE;

-TOCOPHEROL; 7Β-HYDROXYCHOLESTEROL; 7Β-OHCH; CFF; COENZYME Q(10); COQ(10); CRITICAL FLICKER FREQUENCY; FATIGUE; HODE; HYDROXYOCTADECADIENOIC ACID; LIPID PEROXIDATION; OVERNIGHT DESKWORK; QSSF; QUESTIONNAIRES OF SUBJECTIVE SYMPTOMS OF FATIGUE; UBIQUINOL-10; UBIQUINONE-10; UQ(10); UQ(10)H(2); VAS; VISUAL ANALOG SCALE; Α-TOCOPHERYLQUINONE; ΑTQ; ΑTΑ;

ADULT; FATIGUE; HUMANS; HYDROXYCHOLESTEROLS; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; SELF-ASSESSMENT; SLEEP DEPRIVATION; VITAMIN E; WORK;

EID: 84887011347     PISSN: 03010511     EISSN: 18736246     Source Type: Journal    
DOI: 10.1016/j.biopsycho.2013.10.002     Document Type: Article

References (35)

1. Bindokas V.P., Jordán J., Lee C.C., Miller R.J. Superoxide production in rat hippocampal neurons: Selective imaging with hydroethidine. The Journal of Neuroscience 1996, 16(4):1324-1336.
2. Hartley L.R., Arnold P.K., Smythe G., Hansen J. Indicators of fatigue in truck drivers. Applied Ergonomics 1994, 25(3):143-156.
3. Kanazawa H., Miyata C., Nagata Y., Urano S., Matsushima Y. Determination of alpha-tocopherol and alpha-tocopherylquinone in rat tissues and plasma by high-performance liquid chromatography with electrochemical detection. Chemical and Pharmaceutical Bulletin 2000, 48(10):1462-1466.
4. Kaseda Y., Jiang C., Kurokawa K., Mimori Y., Nakamura S. Objective evaluation of fatigue by event-related potentials. Journal of the Neurological Sciences 1998, 158(1):96-100.
5. Kitano S., Yoshida Y., Kawano K., Hibi N., Niki E. Oxidative status of human low density lipoprotein isolated by anion-exchange high-performance liquid chromatography - Assessment by total hydroxyoctadecadienoic acid, 7-hydroxycholesterol, and 8-iso-prostaglandin F(2alpha). Analytica Chimica Acta 2007, 585(1):86-93.
6. Kos D., Nagels G., D'Hooghe M.B., Duportail M., Kerckhofs E. A rapid screening tool for fatigue impact in multiple sclerosis. BMC Neurology 2006, 6:27.
7. Luczak A., Sobolewski A. Longitudinal changes in critical flicker fusion frequency: An indicator of human workload. Ergonomics 2005, 48(15):1770-1792.
8. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Coenzyme Q10 deficiency in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is related to fatigue, autonomic and neurocognitive symptoms and is another risk factor explaining the early mortality in ME/CFS due to cardiovascular disorder. Neuro Endocrinology Letters 2009, 30(4):470-476.
9. Maes M., Mihaylova I., Kubera M., Uytterhoeven M., Vrydags N., Bosmans E. Lower plasma Coenzyme Q10 in depression: A marker for treatment resistance and chronic fatigue in depression and a risk factor to cardiovascular disorder in that illness. Neuro Endocrinology Letters 2009, 30(4):462-469.
10. Maes M., Kubera M., Obuchowiczwa E., Goehler L., Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuro Endocrinology Letters 2011, 32(1):7-24.
11. Marziale M.H., Rozestraten R.J. Alternating shifts: Mental fatigue in nurses. Revista LatinoAmericana de Enfermagem 1995, 3(1):59-78.
12. Matsura T., Yamada K., Kawasaki T. Difference in antioxidant activity between reduced coenzyme Q9 and reduced coenzyme Q10 in the cell: Studies with isolated rat and guinea pig hepatocytes treated with a water-soluble radical initiator. Biochimica Biophysica Acta 1992, 1123(3):309-315.
13. Miwa K., Fujita M. Fluctuation of serum vitamin E (alpha-tocopherol) concentrations during exacerbation and remission phases in patients with chronic fatigue syndrome. Heart and Vessels 2010, 25(4):319-323.
14. Mizuno K., Tanaka M., Nozaki S., Mizuma H., Ataka S., Tahara T., Sugino T., Shirai T., Kajimoto Y., Kuratsune H., Kajimoto O., Watanabe Y. Antifatigue effects of coenzyme Q10 during physical fatigue. Nutrition 2008, 24(4):293-299.
15. Moore A.N., Ingold K.U. Alpha-Tocopheryl quinone is converted into vitamin E in man. Free Radical Biology and Medicine 1997, 22(5):931-934.
16. Murphy M.E., Kolvenbach R., Aleksis M., Hansen R., Sies H. Antioxidant depletion in aortic crossclamping ischemia: Increase of the plasma alpha-tocopheryl quinone/alpha-tocopherol ratio. Free Radical Biology and Medicine 1992, 13(2):95-100.
17. Neuzil J., Witting P.K., Stocker R. Alpha-tocopheryl hydroquinone is an efficient multifunctional inhibitor of radical-initiated oxidation of low density lipoprotein lipids. Proceedings of National Academy of Sciences of the United States of America 1997, 94(15):7885-7890.
18. Niepel G., Bibani R.H., Vilisaar J., Langley R.W., Bradshaw C.M., Szabadi E., Constantinescu C.S. Association of a deficit of arousal with fatigue in multiple sclerosis: Effect of modafinil. Neuropharmacology 2013, 64:380-388.
19. Niki E. Tocopherylquinone and tocopherylhydroquinone. Redox Report 2007, 12(5):204-210.
20. Nozaki S., Sugino T., Kajimoto Y., Kuratsune H., Kajimoto O., Watanabe Y. Mental and physical fatigue-related biochemical alterations. Nutrition 2009, 25(1):51-57.
21. Ravaglia G., Forti P., Lucicesare A., Pisacane N., Rietti E., Mangialasche F., Cecchetti R., Patterson C., Mecocci P. Plasma tocopherols and risk of cognitive impairment in an elderly Italian cohort. The American Journal of Clinical Nutrition 2008, 87(5):1306-1313.
22. Reimund E. The free radical flux theory of sleep. Medical Hypotheses 1994, 43(4):231-233.
23. Shi H., Noguchi N., Niki E. Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radical Biology and Medicine 1999, 27(3-4):334-346.
24. Shichiri M., Yoshida Y., Ishida N., Hagihara Y., Tamai H., Niki E. α-Tocopherol suppresses lipid peroxidation and behavioral and cognitive impairments in the Ts65Dn mouse model of Down syndrome. Free Radical Biology and Medicine 2011, 50(12):1801-1811.
25. Siktar E., Ekinci D., Siktar E., Beydemir S., Gülçin I., Günay M. Protective role of l-carnitine supplementation against exhaustive exercise-induced oxidative stress in rats. European Journal of Pharmacology 2011, 668(3):407-413.
26. Simonson E., Brozek J. Flicker fusion frequency; background and applications. Physiological Reviews 1952, 32(3):349-378.
27. Suda M., Fukuda M., Sato T., Iwata S., Song M., Kameyama M., Mikuni M. Subjective feeling of psychological fatigue is related to decreased reactivity in ventrolateral prefrontal cortex. Brain Research 2009, 1252:152-160.
28. Süer C., Dolu N., Artis A.S., Sahin L., Yilmaz A., Cetin A. The effects of long-term sleep deprivation on the long-term potentiation in the dentate gyrus and brain oxidation status in rats. Neuroscience Research 2011, 70(1):71-77.
29. Takeyama H., Itani T., Tachi N., Sakamura O., Murata K., Inoue T., Takanishi T., Suzumura H., Niwa S. Effects of a modified ambulance night shift system on fatigue and physiological function among ambulance paramedics. Journal of Occupational Health 2009, 51(3):204-209.
30. Valente M., Cavallini L. Inhibition of lipid peroxidation by alpha-tocopherolquinone and alpha-tocopherolhydroquinone. Biochemistry International 1985, 10(5):753-761.
31. Yoshida Y., Hayakawa M., Habuchi Y., Niki E. Evaluation of the dietary effects of coenzyme Q in vivo by the oxidative stress marker, hydroxyoctadecadienoic acid and its stereoisomer ratio. Biochimica Biophysica Acta 2006, 1760(10):1558-1568.
32. Yoshida Y., Kodai S., Takemura S., Minamiyama Y., Niki E. Simultaneous measurement of F2-isoprostane, hydroxyoctadecadienoic acid, hydroxyeicosatetraenoic acid, and hydroxycholesterols from physiological samples. Analytical Biochemistry 2008, 379(1):105-115.
33. Yoshida Y., Yoshikawa A., Kinumi T., Imai Y., Niki E. Hydroxyoctadecadienoic acid and oxidatively modified peroxiredoxins in the blood of Alzheimer's disease patients and their potential as biomarkers. Neurobiology Aging 2009, 30(2):174-185.
34. Yoshida Y., Imai Y., Sawai Y., Saito Y., Fukuda K., Niki E. Hydroxyoctadecadienoic acid as a potential biomarker for oxidative stress in patients with chronic hepatitis C. Journal of Gastroenterology Hepatology 2010, 25(1):107-115.
35. Yoshihara A., Yamanaka K., Kawakami M. Effects of polyphenol on visual fatigue caused by VDT work. International Journal of Occupational Safety and Ergonomics 2009, 15(3):339-343.